PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: rfXcel Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CorePharma Selects rfXcel for California ePedigree Compliance - Pharmaceutical Industry's Easiest to Use and Most Production-Proven E-Pedigree Solution to Insure California Compliance for CorePharma
CorePharma Selects rfXcel for California ePedigree Compliance

 

NewswireToday - /newswire/ - San Ramon, CA, United States, 2008/01/21 - Pharmaceutical Industry's Easiest to Use and Most Production-Proven E-Pedigree Solution to Insure California Compliance for CorePharma.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

rfXcel Corporation, a leading provider of ePedigree Management solutions that allow manufacturers, distributors, and retailers to track the chain of custody of prescription drugs through the pharmaceutical supply chain, today announced that CorePharma has selected rfXcel’s ePedigree Management solution to protect its supply chain from the threat of counterfeit drugs.

Based in Middlesex, NJ, CorePharma is a generic pharmaceutical manufacturer of prescription and over-the-counter products. CorePharma was established in 1998 and has US FDA registered facilities, in compliance with cGMP, EPA, and local government regulations.

In preparation for compliance with California’s pending 2009 ePedigree requirements, CorePharma selected rfXcel’s ePedigree Management solution, after evaluating the leading ePedigree software providers. rfXcel was selected for its certified conformance to the EPCglobal Drug Pedigree Standard, and its successful track record in getting its existing customers into production, generating Pedigrees for all 50 states. rfXcel’s rich set of features, and the ease with which it is to implement, integrate and use, put it’s solution over the top. Seamlessly integrating to CorePharma’s back-end systems will result in a fully automated system with minimal disruption to its current business processes.

“In selecting rfXcel’s production-proven and EPCglobal certified ePedigree Management solution, CorePharma has taken a major step forward in securing its supply chain from the threat of counterfeits”, said Glenn Abood, Founder and CEO at rfXcel. “With the challenges associated with complying with the 2009 California ePedigree and Serialization requirements, CorePharma chose to protect its drug products with a solution that provides them the greatest value at the lowest Total Cost of Ownership”.

About rfXcel Corporation

rfXcel, founded in 2003, is headquartered in San Ramon, CA. rfXcel (rfxcel.com) is a pioneer in creating real-time supply-chain performance improvement applications for retailers, manufacturers and distributors. rfXcel solutions can be implemented today, yet have the capability to scale as infrastructure technology develops. The rfXcel management team and board are comprised of industry experts that come directly from the life sciences, technology and consumer goods industries. rfXcel was founded on the principal of providing real business value to our customers by developing solutions that solve supply chain problems that they face every business day.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: rfXcel Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CorePharma Selects rfXcel for California ePedigree Compliance

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Ensell - rfXcel.com 
925-325-0584 jensell[.]rfxcel.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any rfXcel Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From rfXcel Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)